Exchange: NYSEMkt·Updated 12:05 PM EDT
CLDI logo

CLDI Calidi Biotherapeutics Inc - Ordinary Shares - Class A

$1.06
$0.0738
(6.53%)
Today
Mkt Cap$4.15M
Vol119,649.00

About CLDI

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
66

Bullish Sentiment

How do you feel about CLDI?

Advertisement|Remove ads.